VOXYVOTE

Medicare Officially Limits Coverage of Aduhelm to Patients in Clinical Trials

Written by

PAM BELLUCK

in

Officials cited data showing the new Alzheimer’s drug has serious safety risks and may not help patients.

Comments

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

More posts